Literature DB >> 14899586

Neuropharmacologic considerations in psychic seizures.

J E P TOMAN.   

Abstract

Entities:  

Keywords:  EPILEPSY/therapy

Mesh：

Year:  1951        PMID： 14899586     DOI： 10.1212/wnl.1.11-12.444

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Development and pharmacologic characterization of the rat 6 Hz model of partial seizures.

Authors:  Cameron S Metcalf; Peter J West; Kyle E Thomson; Sharon F Edwards; Misty D Smith; H Steve White; Karen S Wilcox
Journal:  Epilepsia       Date:  2017-04-27       Impact factor: 5.864

2.  SCN3A deficiency associated with increased seizure susceptibility.

Authors:  Tyra Lamar; Carlos G Vanoye; Jeffrey Calhoun; Jennifer C Wong; Stacey B B Dutton; Benjamin S Jorge; Milen Velinov; Andrew Escayg; Jennifer A Kearney
Journal:  Neurobiol Dis       Date:  2017-02-22       Impact factor: 5.996

3.  Efficacy of the ketogenic diet in the 6-Hz seizure test.

Authors:  Adam L Hartman; Megan Lyle; Michael A Rogawski; Maciej Gasior
Journal:  Epilepsia       Date:  2007-12-06       Impact factor: 5.864

Review 4.  The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach?

Authors:  Wolfgang Löscher
Journal:  Neurochem Res       Date:  2016-08-08       Impact factor: 3.996

5.  Loss of presenilin 2 age-dependently alters susceptibility to acute seizures and kindling acquisition.

Authors:  Megan Beckman; Kevin Knox; Zachery Koneval; Carole Smith; Suman Jayadev; Melissa Barker-Haliski
Journal:  Neurobiol Dis       Date:  2019-12-17       Impact factor: 5.996

6.  Huperzine A Provides Robust and Sustained Protection against Induced Seizures in Scn1a Mutant Mice.

Authors:  Jennifer C Wong; Stacey B B Dutton; Stephen D Collins; Steven Schachter; Andrew Escayg
Journal:  Front Pharmacol       Date:  2016-10-17       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.